Don't Limit Aggrenox Pay For Delay Discovery, Judge Told
Boehringer Ingelheim and Teva told a Connecticut federal court Friday it would be "profoundly unfair" to limit discovery in a pay-for-delay case over Aggrenox solely to that medication, insisting the relevant...To view the full article, register now.
Already a subscriber? Click here to view full article